Cargando…

Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol

BACKGROUND AND OBJECTIVES: Many low-income and middle-income countries experience problems with open drug scenes and drug-related community issues (DRCIs). These experiences occur in settings with varying levels of health and law enforcement initiatives, and accordingly a range of approaches are imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Saberi Zafarghandi, Mohammad Bagher, Eshrati, Sahar, Vameghi, Meroe, Ranjbar, Hadi, Arezoomandan, Reza, Clausen, Thomas, Waal, Helge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797387/
https://www.ncbi.nlm.nih.gov/pubmed/31619425
http://dx.doi.org/10.1136/bmjopen-2019-030488
_version_ 1783459815155040256
author Saberi Zafarghandi, Mohammad Bagher
Eshrati, Sahar
Vameghi, Meroe
Ranjbar, Hadi
Arezoomandan, Reza
Clausen, Thomas
Waal, Helge
author_facet Saberi Zafarghandi, Mohammad Bagher
Eshrati, Sahar
Vameghi, Meroe
Ranjbar, Hadi
Arezoomandan, Reza
Clausen, Thomas
Waal, Helge
author_sort Saberi Zafarghandi, Mohammad Bagher
collection PubMed
description BACKGROUND AND OBJECTIVES: Many low-income and middle-income countries experience problems with open drug scenes and drug-related community issues (DRCIs). These experiences occur in settings with varying levels of health and law enforcement initiatives, and accordingly a range of approaches are implemented to curb the problem. Most of the published literature stems from Western and high-income societies. With this concern, the present study aims to describe a planned project to explore DRCIs in the open drug scenes of Tehran, including its typology, and predisposing and reinforcing factors. In addition, the study attempts to investigate the perceptions with respect to the required interventions and barriers to their accessibility. METHODS: To this end, the current study focuses on the Farahzad drug scene due to its structure and the difficult access to the scene by harm reduction providers. Data collection techniques encompass field observation, indepth interview and focus group discussion. Further, semistructured interviews are conducted with people who use drugs and other key informants who are engaged at this drug scene, including business, community, voluntary and statutory stakeholders, for an average of 90 min (average of 45 min for each part of the study). Furthermore, as a complementary method, field observation is performed regarding the themes of DRCIs at this scene. Then, focus group discussions are held to further describe the themes of DRCIs as well as to explore the required interventions, for an average of 90 min. Finally, the results are evaluated using qualitative content analysis. ETHICS AND DISSEMINATION: Ethical approval for the study was obtained from the Ethics Committee of Iran University of Medical Sciences, Iran. Additionally, participants are to provide written informed consent. The findings of the study are expected to play a role in promoting the current intervention.
format Online
Article
Text
id pubmed-6797387
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67973872019-10-31 Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol Saberi Zafarghandi, Mohammad Bagher Eshrati, Sahar Vameghi, Meroe Ranjbar, Hadi Arezoomandan, Reza Clausen, Thomas Waal, Helge BMJ Open Public Health BACKGROUND AND OBJECTIVES: Many low-income and middle-income countries experience problems with open drug scenes and drug-related community issues (DRCIs). These experiences occur in settings with varying levels of health and law enforcement initiatives, and accordingly a range of approaches are implemented to curb the problem. Most of the published literature stems from Western and high-income societies. With this concern, the present study aims to describe a planned project to explore DRCIs in the open drug scenes of Tehran, including its typology, and predisposing and reinforcing factors. In addition, the study attempts to investigate the perceptions with respect to the required interventions and barriers to their accessibility. METHODS: To this end, the current study focuses on the Farahzad drug scene due to its structure and the difficult access to the scene by harm reduction providers. Data collection techniques encompass field observation, indepth interview and focus group discussion. Further, semistructured interviews are conducted with people who use drugs and other key informants who are engaged at this drug scene, including business, community, voluntary and statutory stakeholders, for an average of 90 min (average of 45 min for each part of the study). Furthermore, as a complementary method, field observation is performed regarding the themes of DRCIs at this scene. Then, focus group discussions are held to further describe the themes of DRCIs as well as to explore the required interventions, for an average of 90 min. Finally, the results are evaluated using qualitative content analysis. ETHICS AND DISSEMINATION: Ethical approval for the study was obtained from the Ethics Committee of Iran University of Medical Sciences, Iran. Additionally, participants are to provide written informed consent. The findings of the study are expected to play a role in promoting the current intervention. BMJ Publishing Group 2019-10-16 /pmc/articles/PMC6797387/ /pubmed/31619425 http://dx.doi.org/10.1136/bmjopen-2019-030488 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Saberi Zafarghandi, Mohammad Bagher
Eshrati, Sahar
Vameghi, Meroe
Ranjbar, Hadi
Arezoomandan, Reza
Clausen, Thomas
Waal, Helge
Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title_full Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title_fullStr Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title_full_unstemmed Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title_short Drug-related community issues and the required interventions in open drug scenes in Tehran, Iran: a qualitative study protocol
title_sort drug-related community issues and the required interventions in open drug scenes in tehran, iran: a qualitative study protocol
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797387/
https://www.ncbi.nlm.nih.gov/pubmed/31619425
http://dx.doi.org/10.1136/bmjopen-2019-030488
work_keys_str_mv AT saberizafarghandimohammadbagher drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT eshratisahar drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT vameghimeroe drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT ranjbarhadi drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT arezoomandanreza drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT clausenthomas drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol
AT waalhelge drugrelatedcommunityissuesandtherequiredinterventionsinopendrugscenesintehraniranaqualitativestudyprotocol